Navigation Links
Wes Wheeler Appointed as CEO by Marken's Board of Directors

LONDON, May 25, 2011 /PRNewswire/ -- The Marken Board of Directors is pleased to announce the appointment of Wesley P. Wheeler, MBA as Chief Executive Officer. Mr. Wheeler succeeds Gerard Barba, who will remain the Chairman of the Marken Board of Directors.

Marken's Board and executive management team have sought to add an executive such as Mr. Wheeler for his in depth of experience in the life science industry as well as a strong background in logistics to further strengthen market leadership and maintain Marken's solid growth path.

Prior to joining Marken, Wes held the title of President and CEO of Patheon Inc., a top contract manufacturing services company. Wes was also a former President of Valeant Pharmaceuticals International, and has previously held senior executive roles of increasing responsibility in manufacturing, marketing and engineering at GlaxoSmithKline, plc. Preceding his 22 year career in pharmaceuticals, Mr. Wheeler had a successful 12 year career at ExxonMobil. He holds a bachelor's degree in Mechanical Engineering and a Masters of Business Administration.

"As the nature of biopharmaceutical R&D changes, well controlled clinical supply chains will be a significant factor in the success of key life science companies and the industries that support them. The Board and I feel that Wes can bring his experience from the drug manufacturing, biotechnology and traditional pharmaceutical industries to augment an already strong management team and continue Marken's growth," said Gerard Barba, Marken's Chairman.

Mr. Khawar Mann, managing partner, APAX LLP., said: "We are delighted that Wes has agreed to join us at Marken. His operations background and successful track record in the pharmaceutical industry will give us the tools we need to continue building Marken's portfolio of services and geographies, and thus realize our greatest potential as a leading logistics services provider."

About Marken

Founded in 1980, Marken is focused on supporting the logistics of life Science companies. They manage the global collection, transportation, storage and distribution of specimens and clinical trial supplies. Additionally through their depot network, Marken supports regional storage and distribution of life science materials. Marken's team members and network of facilities bridge the distance between patients and the essential resources of life science companies.

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. David Heimbrook Appointed Chief Executive Officer of SAIC-Frederick, Inc.
2. GRAPHENE-CA appointed an EU Future Emerging Technology flagship pilot
3. David P. Lang Appointed Vice President of CryoLife International, Inc.
4. Olivier BOHUON appointed Chief Executive Officer of Pierre Fabre SA
5. Torbjorn Bjerke Appointed as new CEO for Karolinska Development
6. Shawn Cross Appointed CEO of Burrill Merchant Banking Group
7. New President and CEO appointed at Ocean Nutrition Canada Limited
8. Professor Sander van Deventer Appointed to Supervisory Board of AMT
9. New Board Director Appointed
10. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
11. Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case ... Denmark detail how a patient who developed lymphedema after being treated for breast cancer ... could change the paradigm for dealing with this debilitating, frequent side effect of cancer ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
Breaking Biology News(10 mins):